Form

Rabies post exposure risk assessment form and calendar

Risk assessment form for rabies post exposure treatment.

From:
UK Health Security Agency
Published
31 December 2013
Last updated
7 February 2025 — See all updates

Applies to England

Documents

Rabies post exposure risk assessment form and calendar

Ref: GOV-18168

MS Excel Spreadsheet, 404 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Medicines Control Authority of Zimbabwe has issued an alert on the identification of falsified rabies vaccine in circulation in Zimbabwe in January 2025.

The falsified vaccine is labelled as ‘Abhayrab’, but there are discrepancies in the manufacturer and Zimbabwean registration details. There is no evidence that the product has been distributed outside Zimbabwe.

Healthcare professionals with concerns about a patient who may have received falsified rabies vaccine in Zimbabwe can call the UKHSA Rabies and Immunoglobulin Service (RIgS) for further advice.

The current lots of human rabies immunoglobulin (HRIG) in use in England are:

  • JRC22352C, the potency is 211 IU/ml, vial volume is 3 ml
  • JRC24208, the potency is 345 IU/ml, vial volume is 1.6 ml

Please check the batch number you are issuing.

Return completed risk assessment form to the vaccine clerk, Rabies and Immunoglobulin Service by email to RIGS@ukhsa.gov.uk or PHE.ig.clerks@nhs.net

Updates to this page

Published 31 December 2013
Last updated 7 February 2025 + show all updates

  1. Added version 41, added new batch number and expiry date.

  2. Added information on Zimbabwean rabies vaccine alert.

  3. Added version 40.2, batch number and vial volume updated.

  4. Added version 40.1, batch number updated.

  5. Added version 40, includes updated amended details on letters.

  6. Updated email address.

  7. Updated form.

  8. Updated Movianto 'out of hours' number.

  9. Updated form.

  10. Updated form.

  11. Updated form.

  12. Updated form (version 37) and added information on HRIG

  13. Added updated risk assessment form with version 36.

  14. Added updated risk assessment form with version 35.

  15. Added updated risk assessment form v34.

  16. Added updated risk assessment form v33.

  17. Updated with form version 32.

  18. Added updated risk assessment form (v31).

  19. Added updated risk assessment form and updated the details of the current HRIG in use.

  20. Added new telephone number for the Rabies and Immunoglobulin service.

  21. Updated with form version 29.

  22. Updated with version 28, and details of the new batch of rabies immunoglobulin in use from 1 May 2019.

  23. Updated with form version 27.

  24. Updated with form version 26.

  25. Updated with form version 25.

  26. Updated with form version 24.

  27. Updated with form version 23.

  28. Updated with form version 22.

  29. Updated with form version 21.

  30. Updated to reflect new guidance and current vaccines and HRIG in use.

  31. Updated with v19.

  32. Updated form with v18.

  33. Updated form with v17.

  34. Updated (v16) to include ability to choose category III for primate exposures to head or neck.

  35. Updated form (version 15).

  36. Updated form (version 14), to reflect changes in rabies status of France.

  37. Updated form (version 13) for details of vaccine batch.

  38. This form has been updated to reflect change in risk for exposures in France.

  39. Updated 'Rabies post exposure risk assessment form and calendar', v11.

  40. Updated 'Rabies post exposure risk assessment form and calendar'.

  41. Updated 'Rabies post exposure risk assessment form and calendar'.

  42. Updated 'Rabies post exposure risk assessment form and calendar'.

  43. First published.

Sign up for emails or print this page

Related content